Cargando…
Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model
In patients with type 1 diabetes (T1D), compromised pancreatic β-cell functions are compensated through daily insulin injections or the transplantation of pancreatic tissue or islet cells. However, both approaches are associated with specific challenges. The transplantation of mesenchymal stem cells...
Autores principales: | Park, Yu Mi, Yang, Chang Mo, Cho, Hee Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266974/ https://www.ncbi.nlm.nih.gov/pubmed/35805883 http://dx.doi.org/10.3390/ijms23136877 |
Ejemplares similares
-
Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells
por: Yang, Xiao-Fei, et al.
Publicado: (2017) -
Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
por: Tsai, Pei-Jiun, et al.
Publicado: (2012) -
Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells
por: Um, Soyoun, et al.
Publicado: (2020) -
Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy
por: Zhang, Wei, et al.
Publicado: (2017) -
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
por: Park, Sang-Jin, et al.
Publicado: (2016)